Research Reports
+ Policy Briefs

Mapping Australia's hepatitis C healthcare service needs

Geographical needs-based analyses can help identify areas for priority health service delivery.

Achieving hepatitis B targets in Australia is cost-effective

"The World Health Organization (WHO) has set specific hepatitis B elimination targets for 2030. Thes...

Hepatitis C: think globally, act locally

The World Health Organization (WHO) has set a target for elimination of hepatitis C as a public heal...

A promising start to introduction of new hepatitis C treatment for HIV-infected populations across the world

Real-world data from six countries show promising early outcomes of direct-acting antiviral treatmen...

Inaugural WHO guidelines for hepatitis B and C testing now available

In 2017, the World Health Organization (WHO) published evidence-based guidelines to facilitate incre...

Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia

Event-style testing campaigns with financial incentives are effective in engaging both regular and o...

Estimating risks associated with early reopening in Victoria. (Policy Brief prepared for the Victorian Department of Health and Human Services)

Direct-acting antivirals have increased the number of people being cured of hepatitis C.

The number of people being cured of hepatitis C has improved since the introduction of direct-acting...

The most promising vaccines for COVID-19. (Updated 17.6.2020)

There are currently 11 vaccine candidates for COVID‑19 in clinical trials. Five of the six vaccines ...

A successful pilot of point-of-care hepatitis C testing at community needle and syringe programs

Rapid EC: Point-of-care testing for hepatitis C at needle and syringe programs is feasible and accep...

Hepatitis C elimination requires more than universal availability of treatment

Universal availability of hepatitis C treatment is a critical but insufficient step towards eliminat...

Needle sharing remains the major risk factor for hepatitis C infection

Hepatitis C incidence appears to be decreasing, but in a cohort of people who inject drugs in Melbou...

The importance of injecting networks

Significant and ongoing Burnet Institute research has provided important insights into the social ne...

Predictors of spontaneous hepatitis C clearance after reinfection

Gender and genetics could identify people who are more likely to eliminate hepatitis C after reinfec...

Optimising opportunities to provide harm reduction counselling

Hepatitis C testing in people who inject drugs should be combined with harm reduction counselling to...

Using social networks to reduce hepatitis C prevalence

Targeting social networks with a ‘treat your friends’ approach is a feasible, practical and effectiv...

Targeted and comprehensive intervention is vital for hepatitis C elimination

Elimination of hepatitis C requires effective engagement of people who inject drugs. A targeted comp...

Injecting networks influence hepatitis C transmission

Genetic signatures of the hepatitis C virus demonstrate the important role of injecting networks in ...

Slowly but surely: how to reduce hepatitis C prevalence

Modest increases in hepatitis C treatment rates amongst people who inject drugs will significantly r...

All people who inject drugs should be offered hepatitis C treatment

Evidence supports treatment (pegylated interferon plus ribavirin) of hepatitis C in people who injec...